Glimilm M Tablet 2/500mg

Adult dose

This medication is administered 1-2 times a day before meals or with meals. The dosage can be adjusted based on each patient’s current treatment regimen, efficacy, and tolerability, and appropriate blood sugar monitoring should be performed. Typically, treatment is initiated with a low dose, and the dosage can be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glymepride/metformin hydrochloride

This medication can cause severe lactic acidosis or hypoglycemia; therefore, if there is a sudden deterioration in kidney function or symptoms of dehydration, administration should be temporarily suspended and a doctor should be consulted. Patients with poor kidney function or the elderly should undergo kidney function tests before administration of this medication and regularly check kidney function, and caution is needed for patients at risk of cardiovascular diseases. This medication should not be administered to insulin-dependent diabetes patients, patients with acute metabolic acidosis, patients with severe liver dysfunction, pregnant women or nursing mothers, and patients with severe kidney impairment. Patients at high risk of hypoglycemia, those in a state of malnutrition or irregular eating patterns, and those consuming large amounts of alcohol should be particularly cautious when taking this drug, and immediate action should be taken if hypoglycemic symptoms appear. Gastrointestinal symptoms such as diarrhea, nausea, and vomiting may occur but are usually temporary; if symptoms are severe, consultation with a doctor is necessary. This medication may cause allergic reactions, blood abnormalities, vitamin B12 deficiency, etc., so regular testing is required, and any abnormal symptoms should be immediately reported to healthcare personnel. There are many interactions with other drugs, and blood sugar control may change when used in combination; therefore, if there are any medications currently being taken, it is essential to inform healthcare personnel. Women who are pregnant or planning to become pregnant should not take this medication and should switch to insulin therapy for blood sugar control; it should also be avoided during breastfeeding. Use this medication with caution in children and the elderly, especially in the elderly with reduced kidney function, as dosage adjustments and regular kidney function tests are necessary. Overdosing may cause hypoglycemia or lactic acidosis, so if symptoms are suspected, one should visit a medical institution immediately for appropriate treatment. While taking this medication, it is important to maintain regular meals and exercise, receive regular blood sugar and kidney function tests, and avoid alcohol consumption. Caution should be exercised when driving or operating machinery due to the possibility of impaired alertness from hypoglycemia or hyperglycemia.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, shock, hypotension, thrombocytopenic purpura, platelet count below 10,000/µL, liver abnormalities (jaundice), liver failure, severe allergic reactions, cardiac arrest, lactic acidosis, hypoglycemia, severe edema, severe skin reactions, hemolytic anemia, serious neurological symptoms (encephalopathy, coma, loss of consciousness, seizures, paralysis, confusion, visual disturbances), hematological abnormalities (pancytopenia,

Mild side effects

• Diarrhea
• nausea
• vomiting
• abdominal distension
• loss of appetite
• indigestion
• constipation
• abdominal pain
• gastrointestinal symptoms
• nausea

This medication should be stored in a sealed container to prevent air or moisture from entering. Additionally, avoid storing in excessively hot or cold places and store it at room temperature between 1 degree and 30 degrees Celsius.

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle